Unipath Specialty Laboratory’s Post

3,500+ views and 4 citations in other studies! At @consultfiv , we believe in the power of data and AI as a tool to advance reproductive success, and we are committed to innovation and continuous improvement. Stay tuned for more updates on upcoming advancements!

It’s #DNADay! Check out these examples of how genomics is transforming human lives: ➡️In the UK, the ambitious Newborn Genome Program by Genomics England, running until 2025, aims to sequence the genomes of 100,000 babies. This initiative will revolutionize newborn screening, enabling faster diagnosis and improved access to treatments for rare genetic conditions. Learn more about this groundbreaking effort at https://lnkd.in/eC7-JuVF ➡️The US program All of Us aims to create a vast genomic database with one million participants, partnering with universities and healthcare organizations. This initiative, led by The National Institutes of Health explores how genetics 🧬 + environment 🏞️ + lifestyle 🍽️ impact health. Participate at JoinAllofUs.org for free! #health #NGS #humanresearch #newbornresearch #geneticscreening #science 

Congrats to Edwin Kirk and his many colleagues on their magnum opus out today in the world’s premier medical journal. This large-scale nation-wide demo project on reproductive carrier screening is unlikely to have been doable in the US, and extra kudos for pulling it off during COVID. Of >9k couples screened for c1300 child-onset disease genes, 1.9% were given an at-risk result, with highlight findings around acceptability, low regret, and informed reproductive decision making. Most of us carry a single copy of at least a couple of nasty genes, as did 93% of prospective parents herein, though appropriately results were given only if the couple was at risk. In Australia, Medicare currently funds couple screening for 3 genes, while private providers offer hundreds - there are counselling as well as cost considerations here, so will be interesting to watch how and when this gets translated. But its impact goes well beyond our shores, with the accompanying editorial entitled "Call for a Global Mission". In leveraging UNSW funding back in 2018 to support Ed’s role in this $20M MRFF grant (via the Australian Genomics Health Futures Mission), we discussed as pivotal the aspiration of getting it into the New England Journal of Medicine – Q.E.D. 👏👏👏 https://lnkd.in/gHkU4e_c  A/Prof Alison Archibald @Nigel Laing @Martin Delatyki Saumya Jamuar Adrienne Torda Dr Vinayak Smith Leslie Burnett Jeffrey Braithwaite Sue Walker Daniel MacArthur Paul Scuffham Sean Emery Mark G. Patricia Davidson Professor The Hon Greg Hunt Nadia Levin Mark Butler Erica Bremner Kneipp Anne Ruston Christopher White

🌟 Cracking the Case: The Incredible Hulk Baby Ever wondered how researchers tackle extraordinary cases like the Hulk Baby (This is what I call it)? 💪 It's all about having a solid plan – just like in a detective story! But before we get into it lets recap on the case study - Myostatin mutation associated with muscle hypertrophy in child (AKA Hulk Baby) Imagine a baby born with muscles so strong they could rival the Hulk's! That's exactly what happened when a former professional athlete gave birth to a son who appeared "extraordinarily muscular" from day one. Doctors confirmed that this muscle growth was due to a special genetic mutation that blocked a protein called myostatin. As Hulk Junior grew up, his muscles continued to bulk up, showing just how powerful this genetic tweak can be! 🔍 The Protocol: Imagine it's like a superhero handbook for the study. It lays out every step – from who can join the study to what tests will be done. For Hulk Baby, it guided doctors on how to examine him and what tests to run to confirm the gene mutation. 📜 Why It Matters: Without a protocol, it'd be chaos! By following the protocol, researchers ensure everything's done right, ethically and safe especially in infants . It's like sticking to a recipe – no surprises! 💡 Key Ingredients: Just like any good recipe, the protocol has key ingredients: Background: Setting the scene for the study. Objectives: Clear goals – like figuring out Hulk Baby's mystery. Methods: How to gather and analyze data – physical exams and genetic tests on Hulk Baby and tracking muscle growth over time Safety Rules: Keeping everyone safe during the study – like monitoring Hulk Baby's health. 🌟 The Takeaway: Whether it's solving a mystery or studying Hulk Baby, having a protocol is crucial. It's the roadmap that guides researchers, ensuring every step is taken with care and precision. #clinicalresearch #trialprotocol #superheroscience #genetics #musclegrowth #myostatininhibition #rareconditions #medicalresearch #healthscience #sciencestories #healthdiscoveries #clinicalstudies #HumanBody #geneticmutations #biologyresearch #healthtech #clinicaltrials

𝗚𝗹𝗼𝗯𝗮𝗹 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐬𝐞𝐦𝐢𝐧𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟐𝟓-𝟐𝟎𝟑𝟑) The global artificial insemination market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.15% during 2025-2033. The report provides a detailed analysis of competitors and regions, offering insights into the industry's landscape. It breaks down various segments, giving a clear view of how each part contributes to the overall market. By examining these segments, the report helps identify trends and patterns that may affect future strategies and planning. 𝐆𝐫𝐚𝐛 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/ggjUb86e 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬: ● 𝐑𝐢𝐬𝐢𝐧𝐠 𝐈𝐧𝐟𝐞𝐫𝐭𝐢𝐥𝐢𝐭𝐲 𝐑𝐚𝐭𝐞𝐬: The increasing prevalence of infertility issues is driving the demand for assisted reproductive technologies, including artificial insemination. ● 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬: Advancements in reproductive medicine, such as improved techniques and technologies, are enhancing the success rates of artificial insemination procedures. ● 𝐂𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐋𝐢𝐟𝐞𝐬𝐭𝐲𝐥𝐞𝐬 𝐚𝐧𝐝 𝐃𝐞𝐥𝐚𝐲𝐞𝐝 𝐂𝐡𝐢𝐥𝐝𝐛𝐞𝐚𝐫𝐢𝐧𝐠: The trend of delayed childbearing and changing lifestyles is contributing to the growth of the artificial insemination market. 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐬𝐞𝐦𝐢𝐧𝐚𝐭𝐢𝐨𝐧 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Conceivex Inc. FUJIFILM Irvine Scientific Inc. (FUJIFILM Holdings America Corporation) Genea Limited Genus PLC Hamilton Thorne Inc. Hi-Tech Solutions Kitazato Corporation Pride Angel Rinovum Women’s Health LLC Rocket Medical plc TenderNeeds Fertility LLC Vitrolife Group AB 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/gdFiCke9 #ArtificialInsemination #IVF #marketresearch #business #marketanalysis #markettrends #researchreport #marketreport #marketforecast #marketgrowth #businessinsights #industryanalysis #marketoutlook #growthprojections #marketstatistics #competitiveanalysis #trendanalysis #marketinsights #imarcgroup

𝐔𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐈𝐧𝐟𝐨𝐫𝐦𝐞𝐝 𝐅𝐚𝐦𝐢𝐥𝐲 𝐏𝐥𝐚𝐧𝐧𝐢𝐧𝐠: 𝐓𝐡𝐞 𝐂𝐚𝐫𝐫𝐢𝐞𝐫 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐨𝐢𝐬𝐞𝐝 𝐟𝐨𝐫 𝐄𝐱𝐩𝐥𝐨𝐬𝐢𝐯𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 The Global #Carrier_Screening_Market size was valued at around 𝐔𝐒𝐃 2.09 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023 & is estimated to grow at a CAGR of around 20.7% during the forecast period, i.e., 2024–30. Carrier screening empowers couples by identifying genetic conditions they may be carriers of, enabling informed choices about their reproductive health. MarkNtel Advisors - Market Research Company' 𝐜𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐚 𝐫𝐨𝐚𝐝𝐦𝐚𝐩 𝐟𝐨𝐫 𝐧𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐝𝐲𝐧𝐚𝐦𝐢𝐜 𝐦𝐚𝐫𝐤𝐞𝐭: 🔹𝐌𝐚𝐫𝐤𝐞𝐭 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞: Gain insights into market #size, growth trends, and future direction. 🔹𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬: Understand the impact of factors like expanded carrier screening panels offering broader genetic analysis. 🔹𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: Identify high-growth regions and tailor your strategy accordingly. 🔹𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞: Gain valuable insights into key players and industry #trends. 𝐄𝐦𝐩𝐨𝐰𝐞𝐫 𝐲𝐨𝐮𝐫𝐬𝐞𝐥𝐟 𝐰𝐢𝐭𝐡 𝐝𝐚𝐭𝐚-𝐝𝐫𝐢𝐯𝐞𝐧 𝐤𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐭𝐨 𝐜𝐚𝐩𝐢𝐭𝐚𝐥𝐢𝐳𝐞 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐫𝐚𝐩𝐢𝐝𝐥𝐲 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐟𝐫𝐞𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/g9_PjNk9 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬- Natera, Quest Diagnostics, Fulgent Genetics, Invitae, Eurofins Scientific Finland Oy, OPKO Health, Inc., Thermo Fisher Scientific, Myriad Genetics, Illumina, and many more. #health #carrierscreening #genetictesting #familyplanning #healthcare #marketresearch #reproductivehealth #marketresearchreports #marketanalysis #marketgrowth #industryanalysis #industrygrowth #consulting #marknteladvisors 

Tezted presents: Recent high-quality studies on #tickbornepathogens and #tickborneresearch This week's highlight is: Nature Springer’s Borrelia burgdorferi: Methods and Protocols. Methods in Molecular Biology. Editor Leona Gilbert. https://lnkd.in/gcVN_DDB Book 2024 🔬 Exciting News for Scientists! 🔬 The Methods in Molecular Biology: Borrelia burgdorferi is here to captivate researchers from all corners of science. Whether you're a cell and molecular biologist, a statistician, or a clinical researcher, this book offers a treasure trove of techniques for your studies, ranging from in vitro to clinical research on the elusive Borrelia burgdorferi microbe. 🦠🔬 We've compiled a blend of standard and cutting-edge methods designed to be user-friendly, making them accessible to scientists at every career stage. 📚👩🔬👨🔬 As our understanding of infectious diseases evolves, so should the tools we employ to investigate them. Dive into this comprehensive guide that covers basic, pre-clinical, and clinical research on Borrelia burgdorferi. 📖 Each chapter unveils specific aspects of analysis, delivering detailed protocols, methodologies, and the latest insights in the field. Plus, we explore unconventional wet lab research, including content analysis, using CHATgpt, clinical algorithms for chronic Lyme, establishing a pregnancy Lyme disease biobank, and setting up a prospective study on Lyme in pregnant women. 🌐 Stay at the forefront of Borrelia burgdorferi research with this invaluable resource! Let's advance our knowledge of infectious diseases together. 💪🌍 #Science #BorreliaBurgdorferi #ResearchMethods #InfectiousDiseases #LymeDisease #ScienceDiscoveries #TickbornePathogen #TickborneDisease #Tickplex @tez_ted

🌟 Welcome to The Institute of Women's Health and Genetics at UChicago Medicine! 🌟 We are thrilled to launch our LinkedIn page and connect with our community of healthcare professionals, researchers, and patients. At The Institute of Women’s Health and Genetics, our mission is to advance women’s health through innovative research, exceptional patient care, and a commitment to personalized medicine. Here’s what you can expect from our page: 🔬 Cutting-Edge Research: Insights into our groundbreaking research and discoveries in women’s health and genetics. 💡 Expert Care: Updates on our clinical services and how we’re redefining patient care. 🎓 Educational Resources: Information on our educational programs, presentations, and professional development opportunities. 🤝 Community Engagement: Stories from our patients, staff highlights, and community initiatives that make a difference. We’re excited to share our journey with you and invite you to follow us for the latest updates and opportunities to engage with our work. Together, we’re shaping the future of women’s health and genetics. #WomensHealth #Genetics #UChicagoMedicine #HealthcareInnovation #PatientCare #ResearchExcellence #WomenInMedicine

Heliospect Genomics, a US-based startup, is pushing boundaries in reproductive technology by offering controversial embryo screening services for wealthy couples. The company claims its genomic prediction technology can assess and select embryos based on traits such as IQ, height, sex, and health risk factors, with services costing up to $50,000 for screening 100 embryos. Heliospect’s methods, detailed in undercover footage, have sparked significant ethical debates, as critics question the implications of genetic selection on social inequality and bioethics. Experts, including bioethicists and scientists, warn that this technology could lead to a future where genetics dictate intelligence and other "desirable" traits, potentially reinforcing inequalities. Heliospect has defended its approach, stating that it operates within legal frameworks, yet the debate continues over the potential consequences of screening embryos for intelligence and other traits, raising fundamental concerns about the future of human genetics. #Heliospect #GenomicScreening #IQSelection #EthicsInScience #GeneticPrediction #FutureOfIVF #Bioethics #EmbryoScreening #TechEthics #GeneticsDebate

We’re excited supporting another disruptive diagnostic startup company, to qualify their U.S. clinical and commercial partners to help accelerate #spermosens U.S. market entry. Today’s medical professionals face a large unmet gap in male fertility diagnostics. There is limited awareness and social stigma making this an underdiagnosed condition. Subsequent treatment plans are delayed, adds unnecessary stress and costs to patients, providers and payers. New scientific research have explored the diagnostic potential of JUNO and IZUMO1 key reproductive proteins in understanding male fertility. Finally, with JUNO-Checked there is a novel electrochemical diagnostic platform for male fertility, that will enable patients getting the most optimal treatment choice. https://lnkd.in/grPekkie Contact #scanmedpartners to learn more about this next generation male diagnostic platform.